Goodrx Holdings 

Goodrx Holdings 

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$200,411
$194,006
$194,785
$196,028
Gross Profit
179,412
152,058
177,321
182,609
EBITDA
25,276
37,198
47,742
38,360
EBIT
15,406
24,596
16,929
Net Income
8,536
1,169
5,425
1,119
Net Change In Cash
200,411
194,006
194,785
196,028
Free Cash Flow
91,172
-9,806
17,058
58,024
Cash
296,113
235,710
261,820
273,529
Basic Shares
348,058
341,424
340,761
347,810

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$796,853
$792,324
$750,265
$766,554
Gross Profit
739,256
744,109
683,340
701,475
EBITDA
184,361
153,920
108,824
65,189
EBIT
99,143
84,382
1,156
11,012
Net Income
30,439
16,390
-8,868
-32,828
Net Change In Cash
796,853
792,324
750,265
766,554
Cost of Revenue
-183,944
Free Cash Flow
164,383
113,545
82,526
91,566
Cash
261,820
448,346
672,296
757,165
Basic Shares
356,973
392,172
410,315
412,858

Earnings Calls

QuarterEPS
2026-06-30
$0.04
2026-03-31
$0.07
2025-12-31
$0.09
2025-09-30
$0.08